Ticker Details
Black Diamond Therapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$130.65M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 3.71%
Avg Daily Range (30 D):	$0.15 | 5.38%
Avg Daily Range (90 D):	$0.10 | 3.80%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	1.5M
Avg Daily Volume (90 D):	.95M

Trade Size
Avg Trade Size (Sh.):	147
Avg Trade Size (Sh.) (30 D):	170
Avg Trade Size (Sh.) (90 D):	156

Institutional Trades
Total Institutional Trades:	381
Avg Institutional Trade:	$1.8M
Avg Institutional Trade (30 D):	$.71M
Avg Institutional Trade (90 D):	$.69M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.24M
Avg Closing Trade (30 D):	$.51M
Avg Closing Trade (90 D):	$.52M
Avg Closing Volume:	175.56K

News

May 22, 2026 @ 12:00 PM Black Diamond Therapeutics to Participate in Jeffe... Source: Na

Aug 7, 2025 @ 12:23 PM Black Diamond (BDTX) Q2 Loss Narrows 47% Source: Jesterai

Aug 1, 2025 @ 4:21 PM Clarus (CLAR) Q2 Loss Beats Estimates Source: Jesterai

Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A

Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.77	$-.16	$-.27
Diluted EPS	$-.76	$-.16	$-.26
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-43.21M	$-9.04M	$-15.12M
Operating Income / Loss	$-53.27M	$-11.26M	$-17.61M
Cost of Revenue
Net Cash Flow	$-68.34M	$9.08M	$-9.87M
PE Ratio